As a global company, and as a pharmaceutical company, we have a responsibility to play our part in addressing some of the world’s most pressing challenges.
Sanofi’s integrated Corporate Social Responsibility strategy aims to build a healthier, more resilient world by ensuring access to healthcare for the world’s poorest people and focus to address broader unmet needs. Integrated within the company’s “Play to Win” business strategy, Sanofi’s commitment to society is based on four essential pillars in which Sanofi is uniquely positioned to make a difference and have a greater impact: Affordable Access, R&D for Unmet Needs, Planet Care, and In and Beyond the Workplace.
We commit to ensure global access & affordability to health while helping healthcare systems' sustainability.
Caption: Dr Ariany Widiastuty examines Salim at Penyengat Olak Public Health Center in Jambi Province, Indonesia
Global Health Unit (GHU)
Our autonomous, non-profit business unit to provide access to essential medicines in 40 lower-income countries.
Rare Disease Humanitarian Program
We help patients living with rare diseases who have no access to treatments, through annual donations of 100,000 vials of medicine.
Global Access Plan
We are developing a global access plan for all new products, to make them available within two years of launch in countries where we can have an impact for patients.
More to come
R&D for Unmet Needs
We provide innovative vaccines and medicines to eradicate polio, eliminate sleeping sickness and we aim to reduce childhood cancer deaths.
Caption: Guy, 12 with his father, is the first child to receive an innovative oral treatment for sleeping sickness, in his hometown Mushie in the Democratic Republic of Congo
For 40 years, Sanofi has supplied billions of polio vaccine doses worldwide. Today the end of polio is in sight.
For 21 years, we’ve partnered with the WHO to combat sleeping sickness, and we are committed to eliminating it by 2030. Sanofi is the only pharma company continuing to develop innovative medicine to eliminate the disease.
Cancer is the leading cause of death by disease among children and our R&D teams work to develop innovative medicines for pediatric cancer.
More to come
We continue to minimize the potential environmental impacts of our activities and products throughout their life cycle
Caption: A clean-up operation on Garrarus beach by Sanofi employees, Waterford – Ireland
Sanofi is committed to reach carbon neutrality across all operations and the entire value chain by 2030.
Sanofi will have an eco-design approach for all new products by 2025.
We will remove all pre-formed plastic packaging (blister packs) for syringe vaccines by 2027.
In and Beyond the Workplace
Building an inclusive workplace while engaging with communities.
Caption: Camille Cottin, Environmental Generalist-Ecotoxicology Specialist, with Guilhem Rousselet, Global Packaging Platform, Deguene Ly, Support Business Global External Manufacturing, and Philippe Nicolas, Change Program Coordinator, France
Diverse Senior Leadership
Sanofi is committed to building representative leadership to reflect the diversity of the communities we live and work in.
Social & Economic Engagement in Communities
Sanofi is fostering inclusion and sustainability in the local ecosystems in which it operates.
From Leaders to Citizens
We are embedding CSR in the career development path of our leaders.
More to come
We actively participate in healthcare systems around the world. At Sanofi, we believe that this gives us the responsibility to respect the highest standards of ethics and integrity as well as conducting business in a responsible and sustainable way.
To learn more – find additional examples below
Environmental Social and Governance (ESG) Performance
ESG and commercial considerations are intrinsically linked and ongoing progress in our ESG performance is vital for Sanofi to succeed and grow in a sustainable way.
#WeCanDoMore to Change Lives
Learn about Sanofi’s commitment to do more!